(PNM-38) Has the presentation of erectile dysfunction and benign prostatic hyperplasia changed? A cohort study from a tertiary hospital in Bogotá, Colombia

Abstract Introduction/Objective Erectile dysfunction (ED) has traditionally been considered one of the conditions associated with benign prostatic hyperplasia (BPH). Demographic changes may influence the presentation of these two disorders. We aimed to evaluate, in our population, whether the relationship between ED and BPH has changed in terms of prevalence. Materials and Methods We conducted a retrospective cohort study including patients diagnosed with BPH at Hospital de San José in Bogotá over the past year. The coexistence of ED and other comorbidities was assessed using ICD-10 code N40X. Erectile function was determined with the Erection Hardness Score developed at Hospital de San José, ranging from 0 to 5. Statistical analyses were performed using Jamovi software. Results A total of 300 patients were evaluated between 2023 and 2024, of whom 140 were eligible for analysis. The median age was 66 years (IQR 60–73). The median prostate volume, measured by ultrasound, was 60 grams (IQR 45–80). ED (≤4 points) was observed in 71% of patients, of whom 40% were unable to achieve penetration (<3 points). Regarding comorbidities, 70% of patients had at least one risk factor. Vitamin D deficiency was present in 67.8%, arterial hypertension in 60.7%, diabetes mellitus in 30%, hypercholesterolemia in 29%, hypothyroidism in 22%, and chronic kidney disease in 20%. A trend was observed between prostate volume and ED severity. Conclusions The proportion of ED among patients with BPH has increased. These patients frequently present comorbidities such as arterial hypertension and diabetes mellitus, which may contribute to these outcomes. Financing No conflict.